跳至主要内容
临床试验/CTRI/2020/12/030007
CTRI/2020/12/030007尚未招募4 期

Randomised controlled trial to study the efficacy and safety of low level light therapy and topical 5% minoxidil in the management of androgenetic alopecia in males

AFMRC1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年1月1日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
50% improvement based on likert scale

研究概览

简要总结

Androgenetic alopecia is the most common form of alopecia in males. The treatment modalities for treatment of androgenetic alopecia are minoxidil and finasteride. Low level light therapy is new FDA approved treatment for management of androgenetic alopecia. We want to compare efficacy of LLLT with 5% minoxidil for its treatment.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
Male

入选标准

  • Grade 2-5 Norwood.
  • Hamilton classification.

排除标准

  • use of finasteride or dutasteride within last 6 months
  • Topical hair growth agents within last 3 months 3, History of hair transplantation
  • Systemic disease affecting scalp.

结局指标

主要结局

50% improvement based on likert scale

时间窗: 6 months

次要结局

  • patient satisfaction score 2 or 3 (moderate satisfaction to satisfaction)(6 months)

研究者

发起方
AFMRC
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验